Teva Pharmaceutical Industries Limited (TEVA)
| Previous Close | 16.69 |
| Open | 16.50 |
| Bid | 16.47 x 900 |
| Ask | 16.48 x 900 |
| Day's Range | 16.41 - 16.67 |
| 52 Week Range | 9.35 - 19.31 |
| Volume | |
| Avg. Volume | 6,845,309 |
| Market Cap | 18.724B |
| Beta (5Y Monthly) | 0.87 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.85 |
| Earnings Date | Jan 29, 2025 - Feb 03, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Nov 27, 2017 |
| 1y Target Est | 22.36 |
GlobeNewswireTeva to Present at the 7th Annual Evercore ISI HealthCONx Conference
TEL AVIV, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, and Eric Hughes, Teva’s Executive Vice President of Global R&D and Chief Medical Officer, will present at the 7th Annual Evercore ISI HealthCONx Conference on Thursday, December 5, 2024. The presentation will begin at 8:20 A.M. Eastern Time. To access a live webcast of the presentation, visit Teva’s Investor Relations websit
Insider MonkeyTeva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25
We recently published a list of 12 Best Stocks Under $25 To Invest In Right Now. In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against other best stocks under $25 to invest in right now. A View of the US Stock Market Post-Election As reported […]
